Nuclease p1-mediated enhancement of sensitivity of p-postlabeling test for structurally diverse dna adducts

Carcinogenesis

Volumn 7, Issue 9, 1986, Pages 1543-1551

  Reddy, M Vijayaraj ^a   Randerath, Kurt ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; 7H DIBENZO(C,G)CARBAZOLE; 7H-DIBENZO(C,G)CARBAZOLE; ADENOSINE TRIPHOSPHATE; BENZO[A]PYRENE; CARBAZOLE DERIVATIVE; CARCINOGEN; DIAGNOSTIC AGENT; DNA; MITOMYCIN; NUCLEASE S1; NUCLEOTIDASE; PHOSPHORUS; SAFROLE;

ANIMAL; ARTICLE; FEMALE; METABOLISM; MOUSE; MOUSE STRAIN;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ADENOSINE TRIPHOSPHATE; ANIMAL; ASPERGILLUS NUCLEASE S1; BENZO(A)PYRENE; CARBAZOLES; CARCINOGENS; DNA; FEMALE; MICE; MICE, INBRED STRAINS; MITOMYCIN; MITOMYCINS; NUCLEOTIDASES; PHOSPHORUS RADIOISOTOPES; SAFROLE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0022774562     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/7.9.1543     Document Type: Article

References (53)

1. Doll, R. and Peto, R. (1981)The Causes of Cancer.Oxford University Press, Oxford.
2. Miller, E.C. and Miller, J.A. (1981) Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer, 47, 2327 - 2345.
3. Autrup, H. and Harris, C.C. (1983) Metabolism of chemical carcinogens by human tissues. In Harris, C.C.'and Autrup, H.N. (eds), HumanCarcinogenesis. Academic Press, New York, pp. 169-194.
4. Grunberger, D., Theall, G. and Eisinger, M. (1983) Metabolism and DNA binding of carcinogens in cultured human epidermal cells. In Harris, C.C. and Autrup, H.N. (eds), Human Carcinogenesis.Academic Press, New York, pp. 195-216.
5. Hemminki, K. (1983) Nucleic acid adducts of chemical carcinogens and mutagens. Arch. Toxicol., 52, 249 -285.
6. Weinstein, I.B. (1981) Current concepts and controversies in chemical carcinogenesis. J. Supramol. Struct. Cell. Biochem.,17, 99-120.
7. Baird, W.M. (1979) The use of radioactive carcinogens to detect DNA modifications. In Grover, P.L. (ed.), Chemical Carcinogens and DNA. Vol. 1, CRC Press, Boca Raton, FL, pp. 59-83.
8. Harris, C.C., Yolken, R.H. and Hsu, I.-C. (1982) Enzyme immunoassays: application in cancer research. Methods Cancer Res.,20, 213-243.
9. Kriek, E., Engelse, L.D., Scherer, E. and Westra, J.G. (1984) Formation of DNA modifications by chemical carcinogens: identification, localization and quantification. Biochim. Biophys. Aaa,738, 181-201.
10. Wogan, G.N. and Gorelick, J.N. (1985) Chemical and biochemical dosimetry, of exposure to genotoxic chemicals. Environ. Health Perspect.,62, 5-18.
11. Herron, D.C. and Shank, R.C. (1979) Quantitative high-pressure liquid chromatographic analysis of methyled purines in DNA of rats treated with chemical carcinogens. Anal. Biochem., 100, 58 -63.
12. Bedell, M.A., Lewis, J.G., Billmgs, JC.C. and Swenberg, J.A. (1982) Cell specificity in hepatocarcinogenesis: preferential accumulation of 0-methylguanine in target cell DNA during continuous exposure of rats to 1,2-dimethylhydraz-ine. Cancer Res., 42, 3079 - 3083.
13. Rahn, R.O., Chang, S.S., Holland, J.M. and Shugart, L.R. (1982) A fluoro-metric-HPLC assay for quantitating the binding of benzo(a]pyrene metabolites to DNA. Biochem. Biophys. Res. Common., 109, 262 - 268.
14. Vahakangas, K., Haugen, A. and Harris, C.C. (1985) An applied synchronous fluorescence spectrophotometric assay to study benzo(a)pyrene-diolepoxide-DNA adducts. Carcinogenesis,6, 1109-1116.
15. Muller, R. and Rajewsky, M.F. (1980) Immunological quantification by high-affmity antibodies of 0-ethyldcoxyguanosine in DNA exposed to A-ethyl-N-nitrosourea. Cancer Res., 40, 887-896.
16. Krytopoulos, S.A. and Swann, P.F. (1980) The use of radioimmunoassay to study the formation and disappearance of 0*-methylguanine in mouse liver satellite and main-band DNA following dimethylnitrosamine administration. J. Cancer Res. Clin. Oncol.,98, 127-138.
17. J-n-butylthymidine and 0*-n-butylthy-midine. Carcinogenesis, 3, 547 -552.
18. Wild, C.P., Smart, G., Saffhill, R. and Boyle, J.M. (1983) Radioimmunoassay of 0*-methyldeoxyguanosine in DNA of cells alkylated in vitro and in vivo. Carcinogenesis, 4, 1605 - 1609.
19. Adamkiewicz, J., Eberle, G., Huh, N., Nehls, P. and Rajewsky, M.F. (1985) Quantitation and visualization of alkyl deoxynucleosides in the DNA of mammalian cells by monoclonal antibodies. Environ. Health Perspect., 62, 49 -55.
20. Poirier, M.C., Yuspa, S.H., Weinstein, I.B. and Blobstein, S. (1977) Detection of carcinogen - DNA adducts by radioimmunoassay. Nature,270, 186-188.
21. Leng, M., Sage, E., Fuchs, R.P.P. and Daune, M.P. (1978) Antibodies to DNA modified by the carcinogen A'-acetoxy-A'-2-acetylaminofluorene. FEBS Lett.,92, 207-210.
22. Huitfekit, H.S., Spangler, E.F., Hunt, J.M. and Poirier, M.C. (1986) Immuno-histochemical localization of DNA adducts in rat liver tissue and phenotypically altered foci during oral administration of 2acetylaminofluorcne. Carcinogenesis,7, 123-129.
23. 1-modified DNA detected by enzyme immunoassay. Proc. Natl. Acad. Sci. USA, 78, 4124 -4127.
24. Hertzog, PJ., Smith, J.R.L. and Gamer, R.C. (1982) Production of monoclonal antibodies to guanine imidazole ring-opened aflatoxin B, DNA, the persistent DNA adduct in vivo. Carcinogenesis, 3, 825 - 828.
25. Poirier, M.C., Lippard, SJ., Zwelling, L.A., Ushay, H.M., Kerrigan, D., Thill, C.C., Santella, R.M., Grunberger, D. and Yuspa, S.H. (1982) Antibodies elicited against cri-diamminedichloroplatinum(IT)-modified DNA are specific for ar-diamminedichloroplatinum(II) - DNA adducts formed in vivo andin vitro. Proc. Natl. Acad. Sci. USA, 79, 6443 - 6447.
26. Baan, R.A., Zaalberg, O.B., Fichtinger-Schepman, A.MJ., Muysken-Schoen, M.A., Lansbergen, M.J. and Lohman, P.H.M. (1985) Use of monoclonal and polyclonal antibodies against DNA adducts for the detection of DNA lesions in isolated DNA and in single cells. Environ. Health Perspect., 62, 81 -88.
27. Poirier, M.C., Reed, E., Zwelling, L.A., Ozols, R.F., Litterst, C.L. and Yuspa, S.H. (1985) Polyclonal antibodies to quantitate cis-diamminedichloroplati-num(n)-DNA adducts in cancer patients and animal models. Environ. Health Perspect., 62,89-94.
28. Poirier, M.C., Santella, R., Weinstein, I.B., Grunberger, D. and Yuspa, S.H. (1980) Quantitation of benzo(a)pyrene-deoxyguanosine adducts by radioimmunoassay. Cancer Res.,40, 412-416.
29. Santella, R.M., Hsieh, L.-L., Lin, C.-D., Viet, S. and Weinstein, I.B. (1985) Quantitation of exposure to benzo(a)pyrene with monoclonal antibodies. Environ. Health Perspect., 62, 95 -99.
30. Randerath, K., Reddy, M.V. and Gupta, R.C. (1981) °P-Labeling test for DNA damage. Proc. Natl. Acad. Sci. USA, 78, 6126 -6129.
31. nP-Postlabeling analysis of non-radioactive aromatic carcinogen -DNA adducts. Carcinogenesis,3, 1081-1092.
32. uP-Post-labeling test for covalent DNA binding of chemicals in vivo: application to a variety of aromatic carcinogens and methylaling agents. Carcinogenesis, 5, 231-243.
33. Randerath, E., Agrawal, H.P., Weaver, J.A., Bordelon, C.B. and Randerath, K. (1985) “P-Postlabeling analysis of DNA adducts persisting for up to 42 weeks in the skin, epidermis and dermis of mice treated topically with 7,12-dimeth-ylbenz[a]anthracerte. Carcinogenesis,6, 1117-1126.
34. Randerath, K., Randerath, E., Agrawal, H.P. and Reddy, M.V. (1984) Biochemical (postlabelling) methods for analysis of carcinogen-DNA adducts. In Berlin, A., Draper, M., Hemminki.K. and Vainio.H. (eds), Monitoring Human Exposure to Carcinogenic and Mutagenic Agents. International Agency for Research on Cancer, Lyon, France, IARC Scientific Publications No. 59, pp. 217-231.
35. Randerathd, C., Randerath, E., Agrawal, H.P., Gupta, R.C., Schurdak, M.E. and Reddy, M.V. (1985) Postlabeling methods for carcinogen -DNA adduct analysis. Environ. Health Perspect., 62, 57 - 65.
36. Everson, R.B., Randerath, E., Santella, R.M., Cefalo, R.C., Avitts, T.A. and Randerath, K. (1986) Detection of smoking-related covalent DNA adducts in human placenta. Science, 231, 54 -57.
37. Gupta, R.C. (1985) Enhanced sensitivity of “P-postlabeling analysis of aromatic carcinogen-DNA adducts. Cancer Res., 45, 5656 - 5662.
38. Fujimoto, M., Kuninaka, A. and Yoshino, H. (1974) Substrate specificity of nuclease PI. Agr. Biol. Chem., 38, 1555 - 1561.
39. Fujimoto, M., Fujiyama, K., Kuninaka, A. and Yoshino, H. (1974) Mode of action of nuclease PI on nucleic acids and its specificity for synthetic phos-phodiesters. Agr. Biol. Chem.,38, 2141-2147.
40. Lu, L.-J.W., Disher, R.M., Reddy, M.V. and Randerath, K. (1986) “P-postlabeling assay of transplacental DNA damage induced by the environmental carcinogens safrole, 4-aminobiphenyl and benzo(a)pyrene. Cancer Res., 46, 3046 - 3054.
41. Schurdak, M.E. and Randerath, K. (1985) Tissue-specific DNA adduct formation in mice treated with the environmental carcinogen, 7H-dibenzo(c, g]-carbazole. Carcinogenesis,6, 1271-1274.
42. uP-Post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-I mice. Carcinogenesis, 5,1613 - 1622.
43. -32P]cGMP, and their use in assay of adenylate and guanylate cyclases, and cyclic nucleotide phosphodiesterases. Adv. Cyclic Nucleotide Res.,10, 135 - 167.
44. Reddy, M.V., Gupta, R.C. and Randerath, K. (1981) °P-Base analysis of DNA. Anal. Biochem.,117, 271-279.
45. Tomasz, M., Lipman, R., Snyder, J.K. and Nakanishi, K. (1983) Full structure of a mitomycin C dinudeoside phosphate adduct. Use of differentia] FT-IR spectroscopy in microscale structural studies. J. Am. Chem. Soc., 105, 2059 - 2063.
46. Hashimoto, Y., Shudo, K. and Okamoto, T. (1983) Modification of deoxyribonucleic acid with reductively activated mitomycin C. Structures of modified nucleotides. Chem. Pharm. Bull.,31, 861-869.
47. 1 atom of guanine and N* atom of adenine residues as sites for covalent binding of meta-bdically activated l'-hydroxysafrole to mouse liver DNA in vivo. Cancer Res., 41, 2664 - 2671.
48. uP-Post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. II. Newborn male B6C3F, mice.' Carcinogenesis,5, 1623-1628.
49. Beland, F.A., Beranek, D.T., Dooley, K.L., Heflich, R.H. and Kadlubar, F.F. (1983) Arylamine - DNA adducts in vitro and in vivo: their role in bacterial mutagenesis and urinary bladder carcinogenesis. Environ. Health Perspect., 49, 125-134.
50. Meyer, S. L. (1975) Data Analysis for Scientists and Engineers. John Wiley and Sons, Inc., New York, Chapter 10, p. 40.
51. Randerath, E., Avitts, T.A., Reddy, M.V., Miller, R.H., Everson, R.B. and Randerath, K. (1986) Comparative”P-analysis of cigarette smoke induced DNA damage in human tissue and mouse skin. Cancer Res., in press.
52. Randerath, E., Gupta, R.C., Morris, H.P. and Randerath, K. (1980) Isolation and sequence analysis of two major leucine transfer ribonucleic acids (anticodon Mm-A-A) from a rat tumor, Morris hepatoma 5123D. Biochemistry, 19, 3476 - 3483.
53. uP-postlabeling analysis. Mutat. Res., 152, 85 -96.